To confirm whether CCN2 is a potential biomarker in knee AF and whether CCN2 could be induced by TGF-β, we recruited 30 additional patients, with 10 in the AF group and 20 in the NC group. This evidence concerns the gene CCN2 and atrial fibrillation.